Miss Monika Kaushik
Breast Surgeon
Special Interest
Breast SurgeryOncoplastic SurgeryBreast ReconstructionBreast CancerBreast PainCosmetic Breast Surgery
Language Spoken
English
Accreditations
MBBS, DNB, MRCS, MD, FRCS
Biography
Miss Monika Kaushik is a Consultant Oncoplastic, Reconstructive and Aesthetic Breast Surgeon specialising in the diagnosis and treatment of both benign and malignant breast conditions. She works with patients who need expert breast care, combining cancer surgery with advanced reconstructive and cosmetic techniques to achieve the best possible outcomes for both health and appearance.
Miss Kaushik completed her specialist surgical training in the East Midlands Deanery, with breast oncoplastic surgery as her subspecialty focus, before undertaking a fellowship in oncoplastic breast surgery at Addenbrookes Hospital in Cambridge. She was appointed Consultant at University Hospitals of Leicester NHS Trust in 2013, where she continues to practise alongside her private work.
Her clinical expertise covers a wide range of breast surgery, including oncoplastic and reconstructive procedures, risk-reducing surgery, revision surgery, breast augmentation, breast reduction, and nipple and areolar surgery. She also manages benign breast conditions such as breast pain, breast lumps and nipple discharge, providing a thorough and personalised approach to each patient.
Miss Kaushik holds several leadership roles within her NHS Trust, serving as Breast Surgery Research Lead and Educational Lead for her Management Group. She is committed to service improvement and enhancing the patient experience, and she believes in supporting women through every stage of their care with clarity, kindness and confidence.
She is certified and registered by the Royal College of Surgeons to practise breast cosmetic surgery and is a member of the Medical Breast Network.
Publications:
An optimised patient derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody directed therapy http://www.nature.com/scientificreports. (2024) 14:12833
‘PartBreCon’ study. A UK multicentre retrospective cohort study to assess outcomes following PARTial BREast reCONstruction with chest wall perforator flaps. The Breast: Volume 71, October 2023, Pages 82-88
Axillary sentinel lymph node identification using supermagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study). The Surgeon 21 (2023), Issue 2 p.128-134
The MARECA (national study of management of breast cancer locoregional recurrence and oncological outcomes) study: National practice questionnaire of United Kingdom multi-disciplinary decision making. European Journal of Surgical Oncology Vol. 48 Issue 7 p1510–1519. Published online: April 4, 2022
Bridging pre-surgical endocrine therapy for breast cancer during the COVID-19 pandemic: outcomes from the B-MaP-C study. Breast Cancer Res Treat. 2023 Jun;199(2):265-279. doi: 10.1007/s10549-023-06893-4. Epub 2023 Apr 3
External Validation of a Predictive Model for Acute Skin Radiation Toxicity in the REQUITE Breast Cohort (Collaborator). Front Oncol. 2020 Oct 30;10:575909. doi: 10.3389/fonc.2020.575909. eCollection 2020.
REQUITE: A prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer (Collaborator). Radiother Oncol. 2019 Sep;138:59-67. doi: 10.1016/j.radonc.2019.04.034. Epub 2019 May 27
The impact of immediate breast reconstruction on the time to delivery of adjuvant therapy: the iBRA-2 study (Collaborator). Br J Cancer. 2019 Apr;120(9):883-895. doi: 10.1038/s41416-019-0438-1. Epub 2019 Mar 29
Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity (Collaborator). Radiother Oncol. 2021 Jun;159:241-248. doi: 10.1016/j.radonc.2021.03.024. Epub 2021 Apr 8
Therapeutic mammaplasty is a safe and effective alternative to mastectomy with or without immediate breast reconstruction (Collaborator). Br J Surg. 2020 Jun;107(7):832-844. doi: 10.1002/bjs.11468. Epub 2020 Feb 19
Multicentre prospective observational study evaluating recommendations for mastectomy by multidisciplinary teams. Mastectomy Decisions Audit (MasDA) Collaborative, on behalf of the West Midlands Research Collaborative (Collaborator). Br J Surg. 2020 Feb;107(3):227-237. doi: 10.1002/bjs.11383. Epub 2019 Nov 5
Axillary sentinel lymph node identification using superparamagnetic iron oxide versus radioisotope in early stage breast cancer: The UK SentiMag trial (SMART study). The Surgeon, Volume 21, Issue 2, April 2023, 128-134
A Prospective, single-arm, multicenter clinical evaluation of a new localization technique using non-radioactive magseeds for surgery of clinically occult breast lesions. Clin Radiol 2019 Dec;74(12):974.e7-974.e11
S. Puri, N. Sharma, R.G. Newcombe, M. Kaushik, M. Al-Attar, S. Pascaline, M. Hajaj, M.G. Wallis, B. Elsberger, A. Goyal. Axillary tumour burden in women with one abnormal node on ultrasound compared to women with multiple abnormal nodes. Clinical Radiology (2017), https://doi.org/10.1016/j.crad.2017.12.014
Oliveira-Cunha M, S Shokuhi, Kaushik M. Male Breast Cancer – Single centre experience and current evidence. The Breast Journal 2014: 20(6)674
